Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Merola

Showing results (231-240 of 394) with videos related to

Pageof 40
Sort By:
Journal of the American Academy of Dermatology|September 17, 2019
Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disordersLourdes Perez-Chada, Vanina L Taliercio, Alice B Gottlieb, et al.
International Journal of Women'S Dermatology|May 12, 2017
Developing classification criteria for discoid lupus erythematosus: an update from the World Congress of Dermatology 2015 meetingScott A Elman, Filippa Nyberg, Fukumi Furukawa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 23, 2026
Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC studyVictoria P Werth, Joseph F Merola, Richard Furie, et al.
Dermatology and Therapy|March 13, 2022
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic ArthritisBoni E Elewski, Andrew Blauvelt, Gaia Gallo, et al.
Journal of the American Academy of Dermatology|June 1, 2020
Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension studyAndrew Blauvelt, Kim A Papp, Joseph F Merola, et al.
The Journal of Rheumatology|July 15, 2024
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual MeetingGretchen D Ball, Danielle Yee, Arianna J Zhang, et al.
The Journal of Rheumatology|March 16, 2021
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual MeetingLourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, et al.
The Journal of Rheumatology|March 16, 2021
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual MeetingPhilip J Mease, Leonard H Calabrese, Kristina Callis Duffin, et al.
Dermatology and Therapy|November 12, 2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's PerspectiveMarjolein de Bruin-Weller, Joseph F Merola, Chih-Ho Hong, et al.
JAMA Dermatology|February 8, 2023
Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling ExpansionMaria C Schneeweiss, Timothy J Savage, Richard Wyss, et al.
Pageof 40

Showing results (231-240 of 394) with videos related to

Sort By:
Pageof 40
Journal of the American Academy of Dermatology|September 17, 2019
Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disordersLourdes Perez-Chada, Vanina L Taliercio, Alice B Gottlieb, et al.
International Journal of Women'S Dermatology|May 12, 2017
Developing classification criteria for discoid lupus erythematosus: an update from the World Congress of Dermatology 2015 meetingScott A Elman, Filippa Nyberg, Fukumi Furukawa, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 23, 2026
Litifilimab efficacy on skin outcomes in cutaneous lupus erythematosus in the Phase 2 LILAC studyVictoria P Werth, Joseph F Merola, Richard Furie, et al.
Dermatology and Therapy|March 13, 2022
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic ArthritisBoni E Elewski, Andrew Blauvelt, Gaia Gallo, et al.
Journal of the American Academy of Dermatology|June 1, 2020
Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension studyAndrew Blauvelt, Kim A Papp, Joseph F Merola, et al.
The Journal of Rheumatology|July 15, 2024
Report of the IDEOM Meeting Adjacent to the GRAPPA 2023 Annual MeetingGretchen D Ball, Danielle Yee, Arianna J Zhang, et al.
The Journal of Rheumatology|March 16, 2021
Report of the Skin Research Working Groups From the GRAPPA 2020 Annual MeetingLourdes M Perez-Chada, Alison Kohn, Alice B Gottlieb, et al.
The Journal of Rheumatology|March 16, 2021
Psoriasis and Psoriatic Arthritis in the Context of the COVID-19 Pandemic: A Plenary Session From the GRAPPA 2020 Annual MeetingPhilip J Mease, Leonard H Calabrese, Kristina Callis Duffin, et al.
Dermatology and Therapy|November 12, 2021
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's PerspectiveMarjolein de Bruin-Weller, Joseph F Merola, Chih-Ho Hong, et al.
JAMA Dermatology|February 8, 2023
Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling ExpansionMaria C Schneeweiss, Timothy J Savage, Richard Wyss, et al.
Pageof 40